{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:00:31Z","timestamp":1774990831416,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s11739-023-03502-6","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T19:02:32Z","timestamp":1703185352000},"page":"455-464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Features of infective endocarditis in a contemporary cohort of persons who inject drugs: a matched comparison analysis of long-term prognostic factors"],"prefix":"10.1007","volume":"19","author":[{"given":"Mohammad Said","family":"Ramadan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Bertolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filomena","family":"Boccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Hamieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Peluso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Patauner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca Salvatore","family":"De Santo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Carozza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Zampino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5381-3537","authenticated-orcid":false,"given":"Emanuele","family":"Durante-Mangoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Monaldi Hospital Cardiovascular Infection Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"issue":"14","key":"3502_CR1","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1161\/CIR.0000000000001090","volume":"146","author":"LM Baddour","year":"2022","unstructured":"Baddour LM et al (2022) Management of infective endocarditis in people who inject drugs: a scientific statement from the American Heart Association. Circulation 146(14):e187\u2013e201","journal-title":"Circulation"},{"issue":"1","key":"3502_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/archinte.162.1.90","volume":"162","author":"CH Cabell","year":"2002","unstructured":"Cabell CH et al (2002) Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 162(1):90\u201394","journal-title":"Arch Intern Med"},{"issue":"12","key":"3502_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082665","volume":"8","author":"L Slipczuk","year":"2013","unstructured":"Slipczuk L et al (2013) Infective endocarditis epidemiology over five decades: a systematic review. PLoS ONE 8(12):e82665","journal-title":"PLoS ONE"},{"issue":"19","key":"3502_CR4","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1161\/CIRCULATIONAHA.114.012717","volume":"130","author":"C-J Shih","year":"2014","unstructured":"Shih C-J et al (2014) Long-term clinical outcome of major adverse cardiac events in survivors of infective endocarditis. Circulation 130(19):1684\u20131691","journal-title":"Circulation"},{"issue":"5","key":"3502_CR5","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jacc.2018.10.082","volume":"73","author":"SE Rudasill","year":"2019","unstructured":"Rudasill SE et al (2019) Clinical outcomes of infective endocarditis in injection drug users. J Am Coll Cardiol 73(5):559\u2013570","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"3502_CR6","doi-asserted-by":"publisher","first-page":"ofw157","DOI":"10.1093\/ofid\/ofw157","volume":"3","author":"AG Wurcel","year":"2016","unstructured":"Wurcel AG et al (2016) Increasing infectious endocarditis admissions among young people who inject drugs. Open Forum Infect Dis 3(3):ofw157","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"3502_CR7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/1469-0691.12395","volume":"20","author":"L Alagna","year":"2014","unstructured":"Alagna L et al (2014) Repeat endocarditis: analysis of risk factors based on the International Collaboration on Endocarditis \u2013 Prospective Cohort Study. Clin Microbiol Infect 20(6):566\u2013575","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"3502_CR8","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.athoracsur.2015.03.019","volume":"100","author":"NK Shrestha","year":"2015","unstructured":"Shrestha NK et al (2015) Injection drug use and outcomes after surgical intervention for infective endocarditis. Ann Thorac Surg 100(3):875\u2013882","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"3502_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.amjms.2016.08.010","volume":"352","author":"L Hartman","year":"2016","unstructured":"Hartman L et al (2016) Opiate injection-associated infective endocarditis in the Southeastern United States. Am J Med Sci 352(6):603\u2013608","journal-title":"Am J Med Sci"},{"issue":"1","key":"3502_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12879-021-05914-1","volume":"21","author":"A Damlin","year":"2021","unstructured":"Damlin A, Westling K (2021) Patients with infective endocarditis and history of injection drug use in a Swedish referral hospital during 10 years. BMC Infect Dis 21(1):236\u2013236","journal-title":"BMC Infect Dis"},{"issue":"5","key":"3502_CR11","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jacc.2020.11.062","volume":"77","author":"JM Peric\u00e0s","year":"2021","unstructured":"Peric\u00e0s JM et al (2021) Prospective cohort study of infective endocarditis in people who inject drugs. J Am Coll Cardiol 77(5):544\u2013555","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"3502_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.5220","volume":"1","author":"L Rodger","year":"2018","unstructured":"Rodger L et al (2018) Clinical characteristics and factors associated with mortality in first-episode infective endocarditis among persons who inject drugs. JAMA Netw Open 1(7):e185220","journal-title":"JAMA Netw Open"},{"issue":"4","key":"3502_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1086\/431979","volume":"41","author":"JM Miro","year":"2005","unstructured":"Miro JM et al (2005) Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the international collaboration on endocarditis merged database. Clin Infect Dis 41(4):507\u2013514","journal-title":"Clin Infect Dis"},{"issue":"4","key":"3502_CR14","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1086\/313753","volume":"30","author":"JS Li","year":"2000","unstructured":"Li JS et al (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30(4):633\u2013638","journal-title":"Clin Infect Dis"},{"issue":"44","key":"3502_CR15","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"G Habib","year":"2015","unstructured":"Habib G et al (2015) 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36(44):3075\u20133128","journal-title":"Eur Heart J"},{"issue":"39","key":"3502_CR16","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","volume":"44","author":"V Delgado","year":"2023","unstructured":"Delgado V et al (2023) 2023 ESC guidelines for the management of endocarditis: developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM). Eur Heart J 44(39):3948\u20134042","journal-title":"Eur Heart J"},{"key":"3502_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ejim.2021.08.011","volume":"94","author":"E Durante-Mangoni","year":"2021","unstructured":"Durante-Mangoni E et al (2021) Predictors of long-term mortality in left-sided infective endocarditis: an historical cohort study in 414 patients. Eur J Intern Med 94:27\u201333","journal-title":"Eur J Intern Med"},{"issue":"4","key":"3502_CR18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E et al (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61(4):344\u2013349","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"3502_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0002-8703(02)94802-7","volume":"146","author":"E Durante Mangoni","year":"2003","unstructured":"Durante Mangoni E et al (2003) Risk factors for \u201cmajor\u201d embolic events in hospitalized patients with infective endocarditis. Am Heart J 146(2):311\u2013316","journal-title":"Am Heart J"},{"key":"3502_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/pan\/mpl013","volume":"15","author":"D Ho","year":"2007","unstructured":"Ho D et al (2007) Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Polit Anal 15:199\u2013236","journal-title":"Polit Anal"},{"issue":"3","key":"3502_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/BF02294361","volume":"52","author":"H Bozdogan","year":"1987","unstructured":"Bozdogan H (1987) Model selection and Akaike\u2019s Information Criterion (AIC): the general theory and its analytical extensions. Psychometrika 52(3):345\u2013370","journal-title":"Psychometrika"},{"key":"3502_CR22","unstructured":"Therneau T (2021) A package for survival analysis in R_. R package"},{"key":"3502_CR23","unstructured":"Alboukadel Kassambara, M.K.a.P.B (2021) survminer: drawing survival curves using \u2018ggplot2\u2019"},{"key":"3502_CR24","doi-asserted-by":"publisher","first-page":"570","DOI":"10.32614\/RJ-2021-053","volume":"13","author":"DD Sjoberg","year":"2021","unstructured":"Sjoberg DD, Whiting K, Curry M, Lavery JA, Larmarange J (2021) Reproducible summary tables with the gtsummary package. The R Journal 13:570\u2013580","journal-title":"The R Journal"},{"key":"3502_CR25","unstructured":"Hadley Wickham RF, Henry L, M\u00fcller K (2021) dplyr: a grammar of data manipulation"},{"key":"3502_CR26","unstructured":"Champely S (2020) pwr: basic functions for power analysis"},{"key":"3502_CR27","unstructured":"RStudio Team (2021) RStudio: integrated development environment for R. RStudio, PBC, Boston"},{"issue":"2","key":"3502_CR28","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.hlc.2018.12.016","volume":"29","author":"A Hilbig","year":"2020","unstructured":"Hilbig A, Cheng A (2020) Infective endocarditis in the intravenous drug use population at a tertiary hospital in Melbourne. Australia Heart Lung Circ 29(2):246\u2013253","journal-title":"Australia Heart Lung Circ"},{"issue":"8","key":"3502_CR29","doi-asserted-by":"publisher","first-page":"e0270283","DOI":"10.1371\/journal.pone.0270283","volume":"17","author":"I Khan","year":"2022","unstructured":"Khan I et al (2022) Evolving mortality rates in people who inject drugs: an Australian tertiary hospital observational study on infective endocarditis. PLoS ONE 17(8):e0270283\u2013e0270283","journal-title":"PLoS ONE"},{"issue":"2","key":"3502_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2021.115453","volume":"101","author":"C Tom","year":"2021","unstructured":"Tom C et al (2021) Impact of chronic hepatitis C virus co-infection on outcomes of infective endocarditis in people who inject drugs. Diagn Microbiol Infect Dis 101(2):115453","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"3502_CR31","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1186\/s12879-021-06697-1","volume":"21","author":"V Scheggi","year":"2021","unstructured":"Scheggi V et al (2021) Infective endocarditis in intravenous drug abusers: clinical challenges emerging from a single-centre experience. BMC Infect Dis 21(1):1010","journal-title":"BMC Infect Dis"},{"issue":"6","key":"3502_CR32","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s15010-019-01338-x","volume":"47","author":"L Varela Barca","year":"2019","unstructured":"Varela Barca L et al (2019) Prognostic factors of mortality after surgery in infective endocarditis: systematic review and meta-analysis. Infection 47(6):879\u2013895","journal-title":"Infection"},{"issue":"5","key":"3502_CR33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/archinternmed.2008.603","volume":"169","author":"DR Murdoch","year":"2009","unstructured":"Murdoch DR et al (2009) Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 169(5):463\u2013473","journal-title":"Arch Intern Med"},{"key":"3502_CR34","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1093\/eurheartj\/ehad507","volume":"44","author":"A Sambola","year":"2023","unstructured":"Sambola A et al (2023) Predictors of embolism and death in left-sided infective endocarditis: the European Society of Cardiology EURObservational Research Programme European Infective Endocarditis registry. Eur Heart J 44:4566\u20134575","journal-title":"Eur Heart J"},{"issue":"10","key":"3502_CR35","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/imj.14717","volume":"50","author":"ZM Low","year":"2020","unstructured":"Low ZM et al (2020) Burden of infective endocarditis in an Australian cohort of people who inject drugs. Intern Med J 50(10):1240\u20131246","journal-title":"Intern Med J"},{"issue":"3","key":"3502_CR36","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/cid\/ciz869","volume":"71","author":"S Straw","year":"2019","unstructured":"Straw S et al (2019) Long-term outcomes are poor in intravenous drug users following infective endocarditis. Even After Surgery Clinical Infectious Diseases 71(3):564\u2013571","journal-title":"Even After Surgery Clinical Infectious Diseases"},{"issue":"26","key":"3502_CR37","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1056\/NEJMoa1112843","volume":"366","author":"D-H Kang","year":"2012","unstructured":"Kang D-H et al (2012) Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 366(26):2466\u20132473","journal-title":"N Engl J Med"},{"key":"3502_CR38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ijcard.2014.10.125","volume":"178","author":"F Delahaye","year":"2015","unstructured":"Delahaye F et al (2015) One-year outcome following biological or mechanical valve replacement for infective endocarditis. Int J Cardiol 178:117\u2013123","journal-title":"Int J Cardiol"},{"issue":"10","key":"3502_CR39","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1080\/00015385.2021.1976448","volume":"77","author":"CZ Chong","year":"2022","unstructured":"Chong CZ et al (2022) Clinical outcomes of severe tricuspid valve infective endocarditis related to intravenous drug abuse \u2013 a case series. Acta Cardiol 77(10):884\u2013889","journal-title":"Acta Cardiol"},{"issue":"18","key":"3502_CR40","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1136\/heartjnl-2020-316718","volume":"106","author":"M Anantha-Narayanan","year":"2020","unstructured":"Anantha-Narayanan M et al (2020) Endocarditis risk with bioprosthetic and mechanical valves: systematic review and meta-analysis. Heart 106(18):1413\u20131419","journal-title":"Heart"},{"issue":"1","key":"3502_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.31083\/j.rcm.2021.01.241","volume":"22","author":"F Yasmin","year":"2021","unstructured":"Yasmin F et al (2021) Exploring the impact of the COVID-19 pandemic on provision of cardiology services: a scoping review. Rev Cardiovasc Med 22(1):83\u201395","journal-title":"Rev Cardiovasc Med"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-023-03502-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-023-03502-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-023-03502-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T07:34:05Z","timestamp":1710920045000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-023-03502-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["3502"],"URL":"https:\/\/doi.org\/10.1007\/s11739-023-03502-6","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,21]]},"assertion":[{"value":"16 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Emanuele Durante-Mangoni MD, PhD, Domenico Iossa PhD, Lorenzo Bertolino MD, Maria Paola Ursi MD, Fabiana D\u2019Amico BSc, Arta Karruli MD, Mohammad Said Ramadan MD, Fabian Patauner MD, Raffaella Gallo MD, Anna Maria Peluso MD, Oriana Infante MD, Roberto Andini MD, Rosa Zampino MD, PhD (internal medicine); Mariano Bernardo MSc, Giuseppe Ruocco MSc (microbiology); Giovanni Dialetto MD, Franco Enrico Covino MD, Sabrina Manduca MD, PhD (echocardiography); Alessandro Della Corte MD, PhD, Luca S. De Santo MD, PhD, Antonio Carozza MD, PhD, Marisa De Feo MD, PhD (cardiac surgery); Gerardo Nigro MD, PhD (electrophysiology); Maria Luisa De Rimini MD (nuclear medicine); Nicola Galdieri MD (intensive care).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Members of the Monaldi Hospital Cardiovascular Infection Study Group"}},{"value":"EDM reports research funding for his institution from MSD, Pfizer, Angelini, Infectopharm, and Advanz pharma, and personal fees or fees to participate in advisory boards or speaker\u2019s honoraria from Roche, Genentech, Pfizer, MSD, Angelini, Advanz pharma, Bio-Merieux, Shionogi, Menarini, Abbvie, Sanofi-Aventis, Medtronic, Trx, and DiaSorin.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial support and conflict of interest disclosure"}},{"value":"Data collection was approved by the Ethics Committee of the University of Campania \u201cLuigi Vanvitelli\u201d and AORN Ospedali dei Colli (prot. N. AOC\/011110\/2020). Personal and clinical data were managed in agreement with the Declaration of Helsinki and the General Data Protection Regulation (679\/2016).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"All patients provided informed consent to the anonymous use of their clinical data for scientific purposes.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}